ES2137166T3 - N-acil-s-(2-hidroxialquil)-cisteinas, su preparacion asi como su utilizacion como productos intermedios para la preparacion de inmunoadyuvantes sinteticos y vacunas sinteticas. - Google Patents

N-acil-s-(2-hidroxialquil)-cisteinas, su preparacion asi como su utilizacion como productos intermedios para la preparacion de inmunoadyuvantes sinteticos y vacunas sinteticas.

Info

Publication number
ES2137166T3
ES2137166T3 ES92109834T ES92109834T ES2137166T3 ES 2137166 T3 ES2137166 T3 ES 2137166T3 ES 92109834 T ES92109834 T ES 92109834T ES 92109834 T ES92109834 T ES 92109834T ES 2137166 T3 ES2137166 T3 ES 2137166T3
Authority
ES
Spain
Prior art keywords
preparation
cysteins
acil
immunoadjuvants
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92109834T
Other languages
English (en)
Inventor
Jorg Dr Metzger
Karl-Heinz Dr Wiesmuller
Gunther Dr Prof Dr Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2137166T3 publication Critical patent/ES2137166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS COMPUESTOS DE LA FORMULA I EN LA QUE LOS SUSTITUYENTES X, Y, R, R1 Y R2 TIENEN LOS SIGNIFICADOS MENCIONADOS, SON APROPIADOS PARA LA OBTENCION DE LIPOPEPTIDOS Y LIPOAMINOACIDOS.
ES92109834T 1991-06-17 1992-06-11 N-acil-s-(2-hidroxialquil)-cisteinas, su preparacion asi como su utilizacion como productos intermedios para la preparacion de inmunoadyuvantes sinteticos y vacunas sinteticas. Expired - Lifetime ES2137166T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4119856A DE4119856A1 (de) 1991-06-17 1991-06-17 N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen

Publications (1)

Publication Number Publication Date
ES2137166T3 true ES2137166T3 (es) 1999-12-16

Family

ID=6434074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92109834T Expired - Lifetime ES2137166T3 (es) 1991-06-17 1992-06-11 N-acil-s-(2-hidroxialquil)-cisteinas, su preparacion asi como su utilizacion como productos intermedios para la preparacion de inmunoadyuvantes sinteticos y vacunas sinteticas.

Country Status (8)

Country Link
US (1) US5700910A (es)
EP (1) EP0519327B1 (es)
JP (1) JP3358827B2 (es)
AT (1) ATE184274T1 (es)
DE (2) DE4119856A1 (es)
DK (1) DK0519327T3 (es)
ES (1) ES2137166T3 (es)
GR (1) GR3031849T3 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329309A1 (de) * 1993-08-31 1995-03-09 Rapp Polymere Gmbh Lipopeptid-Verbindungen
DE19652586A1 (de) * 1996-12-17 1998-06-18 Biotechnolog Forschung Gmbh Dhc-Peptid und Mittel
US6706693B1 (en) 1997-08-13 2004-03-16 The Uab Research Foundation Vaccination by topical application of genetic vectors
US20030045492A1 (en) * 1997-08-13 2003-03-06 Tang De-Chu C. Vaccination by topical application of recombinant vectors
US6348450B1 (en) 1997-08-13 2002-02-19 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom and uses thereof
US6716823B1 (en) 1997-08-13 2004-04-06 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom, and uses thereof
CN101332157B (zh) 1998-10-09 2012-01-11 味之素株式会社 半胱氨酸衍生物
US20040009936A1 (en) * 1999-05-03 2004-01-15 Tang De-Chu C. Vaccine and drug delivery by topical application of vectors and vector extracts
US6783947B1 (en) * 1999-09-09 2004-08-31 Dade Behring Marburg Gmbh Protecting groups for biological labeling
AU1581400A (en) * 1999-12-22 2001-07-03 Om Pharma Acyl pseudopeptides bearing a functionalised auxiliary spacer
KR100898844B1 (ko) * 1999-12-22 2009-05-21 옴 파르마 작용기화된 보조 아암을 가진 아실 슈도디펩티드
GB0210183D0 (en) * 2002-05-03 2002-06-12 Avecia Ltd Process
ES2535451T3 (es) 2002-08-12 2015-05-11 The Council Of The Queensland Institute Of Medical Research Nuevos lipopéptidos inmunógenos que comprenden epítopos de linfocitos T auxiliares y de linfocitos T citotóxicos (CTL)
CA2494192C (en) 2002-08-12 2013-01-22 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
CA2598806A1 (en) 2005-02-23 2006-08-31 Uab Research Foundation Alkyl-glycoside enhanced vaccination
US20080076476A1 (en) * 2006-09-22 2008-03-27 Broadcom Corporation, A California Corporation RF transceiver with a plurality of programmable antennas and methods for use therewith
WO2009059328A2 (en) * 2007-11-02 2009-05-07 The Johns Hopkins University Multi- component l2 vaccine for prevention of human papillomavirus infection
MX2011010050A (es) 2009-03-25 2011-12-14 Univ Texas Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos.
DE102009034779A1 (de) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
PL2618842T3 (pl) 2010-09-22 2019-10-31 Ena Therapeutics Pty Ltd Nowa metoda immunostymulacyjna
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
CN102321002B (zh) * 2011-06-08 2014-04-23 成都圣诺科技发展有限公司 半胱氨酸衍生物及其制备方法和用途
EP2732825B1 (en) 2012-11-19 2015-07-01 Invivogen Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist
EP2769738B1 (en) 2013-02-22 2016-07-20 Invivogen Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
CN106232577B (zh) * 2014-04-25 2019-02-22 味之素株式会社 免疫刺激剂
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
DE102016005550B4 (de) 2016-05-09 2024-09-26 Hans-Georg Rammensee Adjuvans zur lnduzierung einer zellulären lmmunantwort
JP7719590B2 (ja) 2017-03-31 2025-08-06 イーナ レスパラトリー ピーティーワイ リミテッド Ｔｌｒアゴニストによる呼吸器感染症の治療

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860893D1 (en) * 1977-06-20 1981-11-05 Ciba Geigy Ag Lipopeptides, process for their preparation and pharmaceutical compositions containing them
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US4318905A (en) * 1980-06-23 1982-03-09 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US4696946A (en) * 1985-08-30 1987-09-29 Schering Corporation Topical Treatment of hyperproliferative skin diseases
US4767853A (en) * 1986-07-21 1988-08-30 Schering Corporation Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof

Also Published As

Publication number Publication date
DE4119856A1 (de) 1992-12-24
GR3031849T3 (en) 2000-02-29
EP0519327B1 (de) 1999-09-08
EP0519327A1 (de) 1992-12-23
JPH05186419A (ja) 1993-07-27
DE59209742D1 (de) 1999-10-14
ATE184274T1 (de) 1999-09-15
US5700910A (en) 1997-12-23
DK0519327T3 (da) 2000-03-20
JP3358827B2 (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
ES2137166T3 (es) N-acil-s-(2-hidroxialquil)-cisteinas, su preparacion asi como su utilizacion como productos intermedios para la preparacion de inmunoadyuvantes sinteticos y vacunas sinteticas.
MX9305894A (es) Azaquinoxalinas, procedimientos para su preparacion y su empleo.
ES2079534T3 (es) Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados.
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ATE128985T1 (de) Hydantoinderivate.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
FI921345A0 (fi) Piperidinderivat.
MX9203496A (es) Derivados de difenilheteroalquilos, la preparacion de los mismos y drogas y cosmeticos preparados a partir de los mismos.
ES2067609T3 (es) 4-hidroxitetrahidropiran-2-onas asi como los correspondientes derivados, sales y esteres de acidos dihidroxicarboxilicos, procedimiento para su preparacion, preparados farmaceuticos asi como productos previos.
ES2079391T3 (es) Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
FI831070L (fi) Salicylsyraderivat, foerfarande foer deras framstaellning, pao dessa foereningar baserade farmaceutprodukter och deras anvaendning
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
ATE120446T1 (de) Substituierte acrylsäureester.
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
GR3026134T3 (en) 4-hydroxy-phenyl-beta-d-glucose monoesters, their method of preparation and their use in the cosmetic, dental-care, pharmaceuticals and food stuff fields.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
FR2659651B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphenylene diamines.
ES2057644T3 (es) Dieteres de hidroquinona, su obtencion y su empleo.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks
MX9100343A (es) Procedimiento para la preparacion de analogos 6-acilo,7-acilo y 6,7-diacilo de forscolina y sus compuestos intermedios

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 519327

Country of ref document: ES